• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.从监狱长和狱警视角看爱尔兰监狱中的丙型肝炎病毒筛查与治疗——一项定性探索
Health Justice. 2018 Dec 19;6(1):23. doi: 10.1186/s40352-018-0081-6.
2
Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.从护士管理者视角看爱尔兰监狱中的丙型肝炎病毒筛查与治疗——一项质性探索
BMC Nurs. 2019 Jun 13;18:23. doi: 10.1186/s12912-019-0347-x. eCollection 2019.
3
Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.阻碍和促进丙型肝炎(HCV)筛查和治疗的因素——囚犯视角的描述。
Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.
4
Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.竞争的优先级和第二次机会——对囚犯通过丙型肝炎连续护理过程的定性探索。
PLoS One. 2019 Sep 11;14(9):e0222186. doi: 10.1371/journal.pone.0222186. eCollection 2019.
5
Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd).开发基于证据的丙型肝炎教育计划,以提高澳大利亚监狱部门的公众健康素养:监狱中的肝炎教育计划(HepPEd)。
Int J Drug Policy. 2024 Jul;129:104461. doi: 10.1016/j.drugpo.2024.104461. Epub 2024 Jul 5.
6
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.评估同伴支持性筛查作为囚犯丙型肝炎病例发现模式。
Harm Reduct J. 2019 Jul 5;16(1):42. doi: 10.1186/s12954-019-0313-7.
7
Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.向囚犯提供 HCV 治疗是一个重要的机会:基于欧洲政策和实践评估的关键原则。
BMC Public Health. 2019 Jan 8;19(1):30. doi: 10.1186/s12889-018-6357-x.
8
Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers.运用名义群体技术,确定改善加拿大联邦监狱惩教人员和医护人员对监狱针具交换项目参与度的感知障碍和促进因素。
Int J Drug Policy. 2024 Aug;130:104540. doi: 10.1016/j.drugpo.2024.104540. Epub 2024 Jul 29.
9
"You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.“你需要一名指定官员”——惩教和司法卫生人员关于在监狱环境中扩大丙型肝炎治疗即预防的建议。
Int J Drug Policy. 2022 Aug;106:103746. doi: 10.1016/j.drugpo.2022.103746. Epub 2022 May 27.
10
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders.识别加拿大魁北克省监狱中选择退出丙型肝炎病毒筛查的障碍和促进因素:一项多层面、多理论的定性研究,涉及惩教和医疗保健专业利益相关者。
Int J Drug Policy. 2022 Nov;109:103837. doi: 10.1016/j.drugpo.2022.103837. Epub 2022 Aug 26.

引用本文的文献

1
A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.监狱中乙肝和丙肝防治项目障碍与促进因素的定性系统评价
J Viral Hepat. 2025 Feb;32(2):e14049. doi: 10.1111/jvh.14049.
2
Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.埃塞俄比亚西北部贡德尔市囚犯中乙型肝炎和丙型肝炎病毒感染及其相关因素。
PLoS One. 2024 Apr 16;19(4):e0301973. doi: 10.1371/journal.pone.0301973. eCollection 2024.
3
Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.通过即时检测 RNA 技术减少监狱中丙型肝炎护理环节障碍:一项采用综合框架对监狱男性进行的定性探索。
Addiction. 2023 Jun;118(6):1153-1160. doi: 10.1111/add.16137. Epub 2023 Feb 12.
4
Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination.加拿大各省监狱丙型肝炎护理的差异:对丙型肝炎微消除的影响。
Can Liver J. 2021 Aug 9;4(3):292-310. doi: 10.3138/canlivj-2020-0035. eCollection 2021 Summer.
5
New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: a cohort study, 2019.2019年爱尔兰男性囚犯中的新型丙型肝炎病毒感染、再感染及相关风险行为:一项队列研究
Arch Public Health. 2021 Jun 8;79(1):97. doi: 10.1186/s13690-021-00623-2.
6
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients.无限制获得直接作用抗病毒药物对被监禁丙型肝炎病毒感染患者的影响。
Clin Mol Hepatol. 2021 Jul;27(3):474-485. doi: 10.3350/cmh.2021.0015. Epub 2021 Feb 19.
7
Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis.注射吸毒人群中丙型肝炎病毒检测的流行率和高危行为:系统评价和荟萃分析。
Subst Abuse Treat Prev Policy. 2020 Aug 24;15(1):64. doi: 10.1186/s13011-020-00306-1.
8
Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.竞争的优先级和第二次机会——对囚犯通过丙型肝炎连续护理过程的定性探索。
PLoS One. 2019 Sep 11;14(9):e0222186. doi: 10.1371/journal.pone.0222186. eCollection 2019.
9
Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.从护士管理者视角看爱尔兰监狱中的丙型肝炎病毒筛查与治疗——一项质性探索
BMC Nurs. 2019 Jun 13;18:23. doi: 10.1186/s12912-019-0347-x. eCollection 2019.

本文引用的文献

1
Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.在封闭环境中治疗 HCV:监狱微环境中的根除努力。
Am J Gastroenterol. 2018 Nov;113(11):1585-1587. doi: 10.1038/s41395-018-0201-x. Epub 2018 Jul 24.
2
Challenges for prison governors and staff in implementing the Healthy Prisons Agenda in English prisons.英国监狱实施“健康监狱计划”面临的挑战——监狱长和工作人员的应对措施。
Public Health. 2018 Sep;162:91-97. doi: 10.1016/j.puhe.2018.06.002. Epub 2018 Jul 7.
3
Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.微环境清除丙型肝炎:一种新的治疗模式。
Am J Gastroenterol. 2018 Nov;113(11):1639-1648. doi: 10.1038/s41395-018-0157-x. Epub 2018 Jun 27.
4
Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project.在监狱人群中实现丙型肝炎病毒近乎消除的示范:莲花格伦惩教中心丙型肝炎治疗项目。
Clin Infect Dis. 2018 Jul 18;67(3):460-463. doi: 10.1093/cid/ciy210.
5
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
6
Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.在惩教机构内对丙型肝炎病毒(HCV)进行普遍的退出式筛查是一项改善公共卫生的有效干预措施。
Int J Prison Health. 2017 Sep 11;13(3-4):192-199. doi: 10.1108/IJPH-07-2016-0028.
7
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.消除注射吸毒者中的丙型肝炎病毒感染:无干扰素直接抗病毒药物治疗新时代的开端。
Int J Drug Policy. 2017 Sep;47:26-33. doi: 10.1016/j.drugpo.2017.08.001.
8
Micro-elimination - A path to global elimination of hepatitis C.微消除——全球消除丙型肝炎的途径。
J Hepatol. 2017 Oct;67(4):665-666. doi: 10.1016/j.jhep.2017.06.033. Epub 2017 Jul 29.
9
Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.探索在社区纤维扫描诊所接受阿片类药物替代治疗的丙型肝炎患者的特征及治疗障碍。
J Transl Int Med. 2017 Jun 30;5(2):112-119. doi: 10.1515/jtim-2017-0017. eCollection 2017 Jun.
10
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.在目标性基层医疗保健环境中为高度边缘化且当前有药物注射史的丙型肝炎人群提供直接作用抗病毒治疗。
Int J Drug Policy. 2017 Sep;47:209-215. doi: 10.1016/j.drugpo.2017.05.032. Epub 2017 Jun 4.

从监狱长和狱警视角看爱尔兰监狱中的丙型肝炎病毒筛查与治疗——一项定性探索

Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.

作者信息

Crowley D, Van Hout M C, Murphy C, Kelly E, Lambert J S, Cullen W

机构信息

Irish College of General Practitioners, Lincoln Place, Dublin, Ireland.

Public Health Institute, Liverpool John Moore's University, Liverpool, UK.

出版信息

Health Justice. 2018 Dec 19;6(1):23. doi: 10.1186/s40352-018-0081-6.

DOI:10.1186/s40352-018-0081-6
PMID:30569249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6755610/
Abstract

BACKGROUND

Prisons are a key location to access Hepatitis C Virus (HCV) infected people who inject drugs (PWID). Prison health care structures are complex and optimising health care delivery to this high need, marginalised and underserved population remains challenging. Despite international guidelines recommending that prisons are a priority location for HCV screening and treatment levels of prisoner engagement in HCV care remain low. Competing priorities between security and healthcare is a key feature of prison health care. A collaborative approach to health care delivery in prisons can maximise the benefits for prisoners, staff and the wider community.

AIM

To identify the barriers and enablers to HCV screening and treatment in Irish prisons and inform the implementation of a HCV screening program within the Irish Prison Services (IPS).

METHODS

Qualitative study using focus group methodology underpinned by grounded theory.

RESULTS

The following themes emerged from the analysis: priority of safety and security, staffing and resources, concerns about personal risk, lack of knowledge, concerns around confidentiality, prisoners' fear of treatment and stigma, timing of screening, use of peer workers, in-reach hepatology and fibroscanning services. The primary role of prison security is to ensure the safety of staff and prisoners with a secondary but important supporting role in health care delivery. Maintaining adequate staffing levels and the provision of training and education were seen as priorities and impacted on prison officers' fear for personal safety and risk of HCV transmission. Opt-out screening and peer support workers had high levels of support among participants.

CONCLUSION

Upscaling HCV management in prisons requires an in-depth understanding of all barriers and facilitators to HCV screening and treatment. Engaging prison officers in the planning and delivery of health care initiatives is a key strategy to optimising the public health opportunity that prisons provides.

摘要

背景

监狱是接触丙型肝炎病毒(HCV)感染的注射吸毒者(PWID)的关键场所。监狱医疗保健结构复杂,向这一有高需求、边缘化且服务不足的人群提供优化的医疗保健服务仍然具有挑战性。尽管国际准则建议监狱是丙型肝炎病毒筛查和治疗的优先场所,但囚犯参与丙型肝炎病毒护理的水平仍然很低。安全与医疗保健之间相互竞争的优先事项是监狱医疗保健的一个关键特征。采用协作方式提供监狱医疗保健服务可以使囚犯、工作人员和更广泛的社区获得最大利益。

目的

确定爱尔兰监狱中丙型肝炎病毒筛查和治疗的障碍与促进因素,并为爱尔兰监狱管理局(IPS)实施丙型肝炎病毒筛查计划提供信息。

方法

采用基于扎根理论的焦点小组方法进行定性研究。

结果

分析得出以下主题:安全与安保的优先级、人员配备与资源、对个人风险的担忧、知识匮乏、对保密性的担忧、囚犯对治疗和耻辱感的恐惧、筛查时间、同伴工作人员的使用、内部肝病学和纤维扫描服务。监狱安全的主要作用是确保工作人员和囚犯的安全,在提供医疗保健方面起次要但重要的支持作用。维持足够的人员配备水平以及提供培训和教育被视为优先事项,并影响到狱警对个人安全和丙型肝炎病毒传播风险的担忧。非强制筛查和同伴支持人员在参与者中获得了高度支持。

结论

扩大监狱中丙型肝炎病毒的管理需要深入了解丙型肝炎病毒筛查和治疗的所有障碍与促进因素。让狱警参与医疗保健举措的规划和实施是优化监狱提供的公共卫生机会的关键策略。